Nonetheless, there is no doubt that HDAC inhibition presents a novel promising avenue for the development of therapeutic strategies for Alzheimer disease and its associated learning and memory impairments. The gene discussed is HDAC9; the disease is early-onset autosomal dominant Alzheimer disease.